Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2016-11-02 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2016
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions during the month. The content focuses on changes in share capital and share issuance activities rather than financial performance, management commentary, or regulatory certifications. This type of document is a periodic regulatory filing reporting share capital movements, which aligns with the category of Share Issue/Capital Change (SHA). The document length is substantial and contains detailed data, so it is not merely an announcement or a certification. Therefore, the appropriate classification is SHA with high confidence.
2016-11-02 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CSPC Pharmaceutical Group Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share issues, repurchases, and related notes referencing the Listing Rules of The Stock Exchange of Hong Kong Limited. The content focuses on reporting changes in share capital and share repurchases, which aligns with announcements regarding share capital changes rather than a full financial report or earnings release. The document is regulatory in nature, providing detailed disclosure of share capital changes and repurchases as required by listing rules. This fits the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues, stock splits, or other capital changes. The document length (6068 characters) and detailed tabular data support it being a substantive disclosure rather than a brief announcement or certification. Therefore, the appropriate classification is SHA with high confidence.
2016-10-07 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks for a listed issuer, CSPC Pharmaceutical Group Limited. It includes detailed information about share issues, share repurchases, and confirmations related to compliance with listing rules. The content focuses on capital changes and share transactions rather than financial results, management commentary, or regulatory certifications. It is not a full financial report, earnings release, or management discussion. The document fits the definition of a Share Issue/Capital Change announcement, as it reports on new share issues and share buybacks.
2016-10-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2016
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, management changes, or legal matters. It is a regulatory filing reporting monthly share capital movements, not a full financial report or announcement of a report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2016-10-03 English
INTERIM REPORT 2016
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including condensed consolidated financial statements, management discussion and analysis, financial highlights, and notes to the financial statements. It covers a six-month period ended 30 June 2016, indicating it is a report for a period shorter than a full fiscal year. The presence of unaudited financial highlights, profit and loss statements, and cash flow statements confirms it is a comprehensive interim or quarterly financial report. The length of the document (15,000 characters) and the inclusion of substantive financial data exclude it from being a mere announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2016
2016-09-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2016
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/08/2016. The content focuses on share capital changes, share options exercised, and related capital structure updates. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical of a capital or financing update. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2016-09-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.